NDC Package 0409-3613-01 Bupivacaine Spinal

Bupivacaine Hydrochloride In Dextrose Injection, Solution Subarachnoid - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0409-3613-01
Package Description:
10 AMPULE in 1 CARTON / 2 mL in 1 AMPULE (0409-3613-11)
Product Code:
Proprietary Name:
Bupivacaine Spinal
Non-Proprietary Name:
Bupivacaine Hydrochloride In Dextrose
Substance Name:
Bupivacaine Hydrochloride
Usage Information:
Bupivacaine Spinal is indicated for the production of subarachnoid block (spinal anesthesia).Standard textbooks should be consulted to determine the accepted procedures and techniques for the administration of spinal anesthesia.
11-Digit NDC Billing Format:
00409361301
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 1724784 - BUPivacaine HCl 0.75 % in 2 ML Injection
  • RxCUI: 1724784 - 2 ML bupivacaine hydrochloride 7.5 MG/ML Injection
  • RxCUI: 1724784 - bupivacaine HCl 0.75 % per 2 ML Injection
  • RxCUI: 1724784 - bupivacaine HCl 15 MG per 2 ML Injection
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Hospira, Inc.
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Subarachnoid - Administration beneath the arachnoid.
  • Sample Package:
    No
    FDA Application Number:
    ANDA071810
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    01-31-2005
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0409-3613-01?

    The NDC Packaged Code 0409-3613-01 is assigned to a package of 10 ampule in 1 carton / 2 ml in 1 ampule (0409-3613-11) of Bupivacaine Spinal, a human prescription drug labeled by Hospira, Inc.. The product's dosage form is injection, solution and is administered via subarachnoid form.

    Is NDC 0409-3613 included in the NDC Directory?

    Yes, Bupivacaine Spinal with product code 0409-3613 is active and included in the NDC Directory. The product was first marketed by Hospira, Inc. on January 31, 2005 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0409-3613-01?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 0409-3613-01?

    The 11-digit format is 00409361301. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20409-3613-015-4-200409-3613-01